参考资料:
[1] Arcellx Announces Pricing Of Initial Public Offering. Retrieved February 4, 2022, from https://ir.arcellx.com/news/news-details/2022/Arcellx-Announces-Pricing-of-Initial-Public-Offering/default.aspx
[2] Arcellx Presents Continued Robust Long-Term Responses From Its CART-DdBCMA Phase 1 Expansion Trial In Patients With Relapsed Or Refractory Multiple Myeloma At The 63rd ASH Annual Meeting And Exposition. Retrieved February 4, 2022, from https://ir.arcellx.com/news/news-details/2021/Arcellx-Presents-Continued-Robust-Long-Term-Responses-from-its-CART-ddBCMA-Phase-1-Expansion-Trial-in-Patients-with-Relapsed-or-Refractory-Multiple-Myeloma-at-the-63rd-ASH-Annual-Meeting-and-Exposition/default.aspx
联系客服